Annual General Meeting

PIONEERING CANNABIS SINCE 2010: COMPANY MILESTONES 2010 APPLIED NJ MD #1 ME ACQUIRED #2 5 Company established as PalliaTech, Inc. a medical device company #4 ΜΑ #3 Oct 2015 first dispensary sales 2015 NJ #5 Q1 2016 entered into partnership agreements NY CA OH #7 # 10 #12 2016 CT FL OR NV AZ #6 #8 #9 #11 MA ME MD CT FL Aug 2018 raised $85M debt facility/ Company name changed to Curaleaf Dec 2016 dispensary license awarded Apr 2018 acquired vertical operation with 4 stores Dec 2016 - acquired 1 of 4 licensed cultivators and processors in the state 2017 Dec 2016 - acquired 1 of 13 vertically integrated licenses NY Aug 2018 awarded processing license May 2017 - awarded 1 of 10 vertically integrated licenses (1) Refer to Company filings on SEDAR for complete deal terms and associated risks and uncertainties. Refer to Slide 8 for details on Select and Grassroots acquisitions. (2) (3) 'HSR' refers to Hart-Scott-Rodino Antitrust Improvements Act. OR NV AZ 2018 MD NV CA Jun 2017 - acquired Oregon-based manufacturer, Groen Nov 2018 acquired operating dispensary AZ Oct 2018 - completes RTO and $400M equity financing Aug 2017 - acquired licensed cultivator Dec 2017 acquired processing license Oct 2017- - acquired dispensary in Las Vegas 2019 MD OH Jun 2019- acquired two vertical licenses CA NV May 2019 – acquired operating dispensary Jan 2019 - provided convertible debt financing and secured option to purchase cultivation, process, dispensary licenses (3) S OH Jan 2019 - awarded processing license Feb 2019 - acquisition of vertical operator with largescale operational greenhouse AZ Jul 2019 - announced acquisition of Grassroots for $875M(1),(2) Mar 2019 announced acquisition of Acres Cannabis, the state's largest cultivator, vertical operator(¹) May 2019 announced acquisition of Select(2) May 2019- acquired option to purchase cultivation and processing licenses ΑΖ Oct 2019- acquired Acres Cannabis' cultivation and processing assets NV S Nov 2019- Announced record earnings & AGM Oct 2019 - announced amended deal terms for Select & expiration of HSR(2)(3) review curáleaf.

View entire presentation